glp-1 drugs in development Evolution of GLP‐1 Receptor Agonists for Diabetes Treatment GLP-1 Receptor Agonists and Research
Description
GLP-1 therapy, by promoting significant weight loss, tackles the main risk factor: fat accumulation around the airway
doi:10.1002/phar.2688 67
A systematic review and meta-analysis of randomized clinical trial
Click on the Pharmacy tab
While dulaglutide is another weekly-dose option, Ozempic typically demonstrates superior overall weight-loss outcomes
"Insulinotropin: glucagon-like peptide I (7-37) co-encoded in the glucagon gene is a potent stimulator of insulin release in the perfused rat pancreas"
